Iovance Biotherapeutics (NASDAQ:IOVA) gains attention in the Nasdaq Index as biotech sentiment and allocation trends shift.

Public health campaigns promoting TB awareness and healthier environments can play a significant role in reducing the incidence of TB and improving overall respiratory health.

A closer look at a recent study reveals that vegans have significantly lower inflammatory markers than vegetarians and meat eaters ...

最近一则关于“素食并非天然更健康”的标题又在网上刷屏——但当你把视线从耸动的标题移向实际数据，会发现故事并不那么简单。波兰一项名为“Not All Plants Are Equal: Diet Quality and Inflammation in ...

By Vijay Kumar Malesu A massive UK Biobank analysis suggests that objective social isolation may modestly increase cancer risk, particularly in women, highlighting how social conditions and lifestyle ...

Waiting for alerts is obsolete — predictive engineering lets cloud systems see trouble coming and fix it before users ever notice. For more than two decades, IT operations has been dominated by a ...

In little moments like when sipping coffee or licking an ice cream cone, it doesn't seem like your body is pulling off a ...

Iovance can secure lucrative follow-on approvals in massive markets such as lung cancer and first-line melanoma for its approved drug Amtagvi. Read why IOVA is a Buy.

A growing body of research has identified the Epstein-Barr virus, best known as the cause of mononucleosis, as the strongest environmental risk factor for developing multiple sclerosis. The connection ...

Why do diabetic wounds refuse to heal? A new scientific review highlights how disruptions in the timing and behavior of ...